Calton & Associates’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,543
Closed -$201K 439
2025
Q2
$201K Buy
12,543
+218
+2% +$3.39K 0.03% 367
2025
Q1
$194K Sell
12,325
-1,799
-13% -$29.7K 0.04% 323
2024
Q4
$232K Buy
14,124
+182
+1% +$3.16K 0.1% 170
2024
Q3
$247K Sell
13,942
-1,412
-9% -$24.5K 0.09% 193
2024
Q2
$269K Buy
15,354
+171
+1% +$2.91K 0.13% 144
2024
Q1
$264K Sell
15,183
-1,548
-9% -$25.9K 0.13% 148
2023
Q4
$270K Buy
+16,731
New +$255K 0.11% 171
2023
Q3
Sell
-17,528
Closed -$274K 147
2023
Q2
$274K Sell
17,528
-5,833
-25% -$90.2K 0.13% 153
2023
Q1
$365K Buy
23,361
+639
+3% +$9.32K 0.17% 129
2022
Q4
$305K Buy
22,722
+5,883
+35% +$80.4K 0.12% 191
2022
Q3
$215K Buy
16,839
+2,489
+17% +$36K 0.12% 186
2022
Q2
$205K Buy
+14,350
New +$212K 0.11% 210

Other funds holding ECAT

Calton & Associates's ECAT Position: Q3 2025 in Review

Calton & Associates sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q3 2025, closing a stake of 12,543 shares — an estimated $201K sold.

Calton & Associates first reported a position in ECAT in Q2 2022 and held it in 12 quarters. The position peaked at $365K in Q1 2023. 74 funds tracked by Wall St. Rank hold ECAT as of Q3 2025.

  • Calton & Associates reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q3 2025 after selling out during the quarter.
  • Calton & Associates sold 12,543 BlackRock ESG Capital Allocation Term Trust shares in Q3 2025, an estimated $201K.
  • Calton & Associates first reported a position in BlackRock ESG Capital Allocation Term Trust in Q2 2022 and held it in 12 quarters.
  • Calton & Associates's BlackRock ESG Capital Allocation Term Trust position peaked at $365K in Q1 2023.
  • 74 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q3 2025.

Based on Calton & Associates's 13F filing for Q3 2025, filed 7 Nov 2025.